Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Submitted by
admin
on September 28, 2014 - 9:43am
Source:
Yahoo/BusinessWire
News Tags:
Ignyta
RXDX-101
non-small cell lung cancer
Headline:
Ignyta Announces Interim Data from RXDX-101 Phase I Clinical Trial at 2014 ESMO Congress
Do Not Allow Advertisers to Use My Personal information
